Use of adamantane amines or structurally similar compounds...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61P 25/00 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2306830

The invention concerns the use of 1-adamantane amines (amantadines) or structurally similar compounds for combating boma disease virus infections and for treating affective diseases and disorders associated with borna disease virus infections in humans and animals. The use of these substances results in rapid and lasting elimination of the symptoms and signs and in the suppression of the virus activity.

L'invention concerne l'utilisation d'amines de 1-adamantane (amantadines) ou de composés de structure analogue pour lutter contre les infections à virus de méningo-encéphalo-myélite zootique, ainsi que pour traiter des pathologies affectives et des troubles liés aux infections de la méningo-encéphalo-myélite zootique chez l'homme et l'animal. Cette utilisation entraîne l'élimination rapide et durable des symptômes et la suppression de l'activité du virus.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of adamantane amines or structurally similar compounds... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of adamantane amines or structurally similar compounds..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adamantane amines or structurally similar compounds... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1667371

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.